AHA comments on Medicaid drug rebate proposed rule for FY 2021

Jul 20, 2020 - 02:39 PM
AHA-OIG-letter

The AHA July 20 submitted comments on proposed Centers for Medicare & Medicaid Services regulations that would support state flexibility in Medicaid drug value-based purchasing arrangements and other changes to the Medicaid drug rebate program for fiscal year 2021.

“The AHA supports innovations in drug purchasing arrangements, so long as these arrangements preserve or enhance patient access to critical medications and result in lower drug costs,” AHA wrote. “As CMS continues to pursue an increase in VBP opportunity, we urge the agency to consider the appropriate balance that must be struck to make these arrangements work effectively for the Medicaid program as well as throughout the health care delivery system.”

AHA also urged the agency to extend the comment period beyond the current 30-day period to allow stakeholders’ thoughtful and careful consideration for assessing the implications of applying VBP arrangements for Medicaid drug coverage and purchasing.

Related News Articles

Headline
Administration rescinds memo pausing federal grants, loans and other financial assistance programs
The White House Office of Management and Budget Jan. 29 rescinded a memo it issued two days earlier directing federal agencies to temporarily pause federal…
Headline
White House pauses federal grants, other programs implicated by executive orders; OMB says Medicare and Medicaid not affected by pause
The White House Office of Management and Budget late Jan. 27 issued a memo directing federal agencies to temporarily pause federal grants, loans and other…
Headline
CMS announces two drug manufacturers to participate in CGT Access Model 
The Centers for Medicare & Medicaid Services Dec. 4 announced that drug manufacturers bluebird bio, inc. (manufacturer of Lyfgenia) and Vertex…
Headline
CMS to allow Medicaid, CHIP coverage for IHS facilities, tribal communities 
The Centers for Medicare & Medicaid Services Oct. 16 approved section 1115 demonstration amendments which will allow Medicaid and Children's Health…
Headline
CMS releases guidance for states to meet Early and Periodic Screening, Diagnostic and Treatment requirements under Medicaid and CHIP
The Centers for Medicare & Medicaid Services Sept. 26 released guidance on state compliance with the Early and Periodic Screening, Diagnostic and Treatment…
Headline
CMS releases state funding notice for participants in gene therapy model 
The Centers for Medicare & Medicaid Services Aug. 15 released a state funding notice for the Cell and Gene Therapy Access Model. The CGT Access Model will…